Impact Health
  • Home
  • About Us
  • Regulatory
  • Products
  • Services
  • Import/Export
  • News
  • Contact Us
Select Page

Breakthrough Discovery May Lead To Alzheimer’s Treatment

Researchers at the University of Manchester have made a discovery which could potentially lead to a new treatment for Alzheimer’s disease.

read more

Incentive Scheme Results In Two New Antimicrobial Drugs

Under the agreement, NHS England pays a fixed annual fee to pharmaceutical firms, in return for the supply of new antimicrobial drugs.

read more

Diamorphine Shortage Could Put Lives At Risk

There has been a warning that a shortage of the drug diamorphine, which is used as a clinical substitute for heroin, may be causing severe problems for patients in England.

read more

Pioneering Cancer Test Start-Up Seeks UK Market

A UK start-up has developed a pioneering cancer test that has already gained US regulatory clearance.

read more

NICE Recommends New Sight Loss Treatment

A new injectable eye medicine has been recommended as a treatment option by the National Institute for Health and Care Excellence (NICE) for two forms of sight loss.

read more

Promising Results For New Asthma Treatment

A new asthma therapy which is being developed by AstraZeneca in collaboration with Avillion has shown positive results from a phase 3 trial.

read more

Insomnia App Could Replace Sleeping Pills

NICE has recommended that a digital app designed to treat insomnia can be prescribed by doctors as an alternative to sleeping pills.

read more

Concern At Slow Uptake Of New Medicines In NHS

The Association of the British Pharmaceutical Industry (ABPI) has expressed concern about the low level of uptake of some new medicines among NHS patients.

read more

New Drug Approved To Treat Chronic Insomnia

The European Commission (EC) has granted marketing authorisation for a new drug called Quvivq, which is manufactured by Idorsia.

read more

NHS Launches Subscription Scheme To Tackle Antibiotic Resistance

The scheme is designed to help combat the growing resistance to antibiotics that is developing worldwide.

read more
« Older Entries

Unit 8, Crayside Industrial Estate, Thames Road, Crayford, Kent, DA1 4RF, UK

Telephone + 44 (0)20 8320 3820

Fax +44 (0)845 833 0839

Email info@impacth.co.uk

Impact Health Limited has been an accredited member of the London Chambers of Commerce since 2009.

Impact Health is license by the British Home office to procure, store and supply Controlled Drugs.

Impact Health is an MHRA approved wholesaler of pharmaceutical products with Wholesale Distribution Authorisation (Human & Veterinary) issued by the British Government

© Copyright Impact Health Ltd. All rights reserved. Privacy Notice